| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |